胰岛素抵抗大鼠高死亡率与Klotho表达关系的研究

来源 :山东大学学报(医学版) | 被引量 : 0次 | 上传用户:qwe6367
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的通过链脲佐菌素(STZ)腹腔注射,建立胰岛素抵抗大鼠模型,探讨胰岛素抵抗大鼠Klotho的表达变化与死亡率的关系。方法出生当日Wistar大鼠80只,随机选取20只为正常对照组(CN组,n=20),其余60只腹腔注射STZ复制胰岛素抵抗模型。选取40只设立胰岛素抵抗组(IR组,n=20)、氨基胍联合川芎嗪治疗组(TMP+AG组,n=20)。分别在造模8、24、32周短尾取空腹血检测血糖(PG)、糖化血清蛋白(GSP)。造模32周后,取其肾脏实时荧光定量RT-PCR,检测Klotho mRNA的表达,Western blot法和免疫组织化学染色方法检测Klotho蛋白表达。结果与胰岛素抵抗组相比,氨基胍联合川芎嗪治疗组大鼠肾脏中Klotho表达明显上升,死亡率明显降低,差异有统计学意义(P<0.05);与正常对照组相比,胰岛素抵抗组Klotho表达明显降低,死亡率明显升高,差异有统计学意义(P<0.05)。结论胰岛素抵抗大鼠肾脏Klotho的表达水平与死亡率相关。 Objective To establish a rat model of insulin resistance by intraperitoneal injection of streptozotocin (STZ) and investigate the relationship between Klotho expression and mortality in insulin resistant rats. Methods 80 Wistar rats were born on the day of birth. Twenty rabbits were randomly selected as normal control group (CN group, n = 20). The remaining 60 rabbits were injected intraperitoneally with STZ replication insulin resistance model. Forty insulin resistance group (IR group, n = 20) and aminoguanidine combined with ligustrazine group (TMP + AG group, n = 20) were selected. Blood glucose (PG) and glycosylated serum protein (GSP) were determined by fasting blood samples at 8, 24 and 32 weeks after modeling. After 32 weeks of modeling, real-time fluorescent quantitative RT-PCR of kidney was used to detect the expression of Klotho mRNA. Klotho protein expression was detected by Western blot and immunohistochemical staining. Results Compared with insulin resistance group, the expression of Klotho in the kidney of aminoguanidine plus ligustrazine group was significantly increased, the mortality rate was significantly lower (P <0.05); compared with the normal control group, insulin resistance group Klotho expression was significantly reduced, the mortality was significantly increased, the difference was statistically significant (P <0.05). Conclusion The expression of Klotho in the kidney of insulin resistance rats is related to the mortality rate.
其他文献
期刊
期刊
目的:观察辛伐他汀与微粒化非诺贝特及二者联合治疗混合性高脂血症的疗效及安全性分析。方法:将150例混合性高脂血症患者,随机分为辛伐他汀(A)组、非诺贝特(B)组和联合治疗(C)组
目的:探讨负压闭式引流治疗糖尿病足合并溃疡的临床疗效和并发症情况。方法:选取2013年2月~2014年2月来我院治疗的糖尿病足合并溃疡患者58例,其中男38例,女20例,采用负压闭式引流
目的:研究对甲状腺功能亢进症患者采取不同疗程碘131治疗的临床效果。方法:将我院2012年2月~2013年3月90例甲亢患者以抽签法随机分为观察组与对照组,2组均采取常规剂量治疗,3个月
目的:分析HBV血清标志物与HBV-DNA定量检测结果。方法采用ELISA检测302份乙肝病毒血清标志物,同时FQ-PCR法定量检测HBV-DNA,对比检测结果。结果血清标志物I(HBeAg、HBcAb、HBsAg)
目的:对奥曲肽联合泮托拉唑治疗肝硬化并上消化道出血的临床治疗效果进行观察。方法:选取从2011年2月~2014年2月收治的126位患有肝硬化并上消化道出血的患者,随机的将所有患者分
目的:系统分析CT在胰腺及肾上腺闭合性损伤患者中的临床诊断效果。方法:所有研究对象在进行CT检查之前半小时内将300ml的2%泛影葡胺溶液1次性口服,同时,在进行检查前再口服300ml
目的研究CPI-17(PKC-potentiated protein phosphatase inhibitory protein-17)通过诱导血管平滑肌细胞表型改变影响动脉粥样硬化形成的作用。方法载脂蛋白E基因敲除(ApoE-kn
目的:探讨中西医结合治疗66例肠易激综合征患者的临床价值和应用效果。方法:我院消化科在2010年1月~2011年11月观察治疗了66例门诊或住院临床确诊的肠易激综合征患者。随机分为